The ICCLE conference, which is conducted in English, is a scientific meeting on Cutaneous Lupus Erythematosus and related autoimmune diseases. This satellite meeting of the International Investigative Dermatology conference will bring together researchers, clinicians, young scientists and residents to assess the state-of-the-art, discuss controversy and present new data. It will lay important groundwork for further developments in the field.
IID Orlando: 1:00-4:30pm Wednesday, May 16, 2018
The psoriatic disease mechanistic scenarios
Moderators: Hervé Bachelez and Johann Gudjonsson
The International Psoriasis Council brings together global scientific leaders in the field of psoriatic disease mechanisms in a two-part symposium. Part 1 of this event will feature four state-of-the-art lecturers with expert panel discussion. The nature and significance of genetic variations identified in plaque psoriasis and psoriatic arthritis will be discussed in view of most recent immunogenetic studies, while a specific address will be given to the contribution of gene expression profiling to the stratification of psoriasis patients. In addition, key immune effector and regulatory immune mechanisms will be examined through experimental mouse models and their relevance to the pathogenesis of psoriasis in humans. Finally, advances in the genetic drivers of pustular psoriasis will be presented with consideration for future targeted treatment. Part 2 will include a series of selected poster presentations that provide additional insights into disease mechanisms that contribute to psoriatic phenotypes.
For further information and to register: http://www.psoriasiscouncil.org/events_education_2018.htm
Pemphigus and Pemphigoid: A New Era of Translational and Clinical Science
The goal of the meeting is to bring together pemphigus and pemphigoid patients, clinicians, researchers, and industry partners to focus on ongoing or future clinical trials and their underlying science. In addition to clinical and scientific data, the agenda includes discussion of disease-specific instruments for use in clinical trials and a panel of patients and industry representatives describing their experience enrolling for clinical trials. The keynote speaker is David Fajgenbaum, MD, MBA, co-founder of the Castleman’s Disease Collaborative Network, who will discuss the role of advocacy and multi center networks for rare disease research. In addition, a limited number of speakers will be selected from submitted abstracts for brief oral presentation or to highlight posters to be presented at IID 2018.
- Abstract submission deadline (email@example.com using IID 2018 abstract guidelines): January 26, 2018
- Abstract decision communicated after February 26, 2018
- Registration deadline: March 19, 2018
REGISTRATION OPENS SOON AT: www.pemphigus.org
Questions? Contact IID2018@pemphigus.org
We are pleased to invite you to the 2018 Jefferson Matrix Satellite Symposium to take place May 13-15, 2018, at Thomas Jefferson University, Philadelphia, PA. Sponsored by DEBRA of America and Matrix Biology, this symposium will focus on Molecular Genetics of Epidermolysis Bullosa.
- Keynote Address: Jouni Uitto, MD, PhD
- Novel Genes and Mutations with Genotype/Phenotype Correlations
(Chair: Leena Bruckner-Tuderman, MD, PhD)
- Therapy Development and Clinical Trials
(Chair: Katsuto Tamai, MD)
- Jouni Uitto, MD, PhD International Visiting Professorship and Lecture in Molecular Dermatology
Recipient: John A. McGrath, MD
- Breakthroughs in EB Research: Young Investigators Forum
(Chair: Andrew South, PhD)
- Patient and Family Perspectives: Brett Kopelan
For further information and to register https://www.jeffersonmatrixbiology.com/
On behalf of the Medical Dermatology Society (MDS) Board of Directors, we cordially invite you to join us for the 2018 MDS Abstract Session. Join your colleagues in Orlando, Florida at the Rosen Shingle Creek Resort on Thursday, May 17, 2018 from 7:00-8:30 am, in the Conway Conference Room. The MDS Abstract Session will highlight the latest advances in medical dermatology research and patient care innovations.
The Medical Dermatology Society (MDS) is a physician organization dedicated to
- Advancing the understanding and treatment of serious dermatologic diseases through education and research
- Exchanging advances in the field of medical dermatology
- Promoting the training of dermatology residents, fellows and practitioners in the pathogenesis and treatment of complex dermatologic diseases.